We are live on ! Find out more
ADAG

Adagene

16 hedge funds and large institutions have $80.5M invested in Adagene in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.29% less ownership

Funds ownership: 12.2%10.92% (-1.3%)

30% less capital invested

Capital invested by funds: $116M → $80.5M (-$35M)

41% less funds holding

Funds holding: 2716 (-11)

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 12

Holders
16
Holders Change
-11
Holders Change %
-40.74%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
5
Reduced
4
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Pinz Capital Management
New York
-$299K -16,667 Closed
Norges Bank
27
Norges Bank
Norway
-$215K -12,000 Closed
Legal & General Group
28
Legal & General Group
United Kingdom
-$54K -3,000 Closed

ADAG Hedge Fund Activity: Q2 2021 in Review

16 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q2 2021, worth a combined $80.5M — down 30% from $116M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ADAG and 1 opened new positions — a net loss of 11 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Morgan Stanley, adding an estimated $13.4M. The largest seller was Credit Suisse, exiting entirely with an estimated $10.9M sold.

  • 16 institutional investors held Adagene (ADAG) as of Q2 2021, down from 27 in Q1 2021.
  • Funds reported $80.5M of Adagene stock for Q2 2021, down 30% quarter-over-quarter.
  • 1 fund opened new Adagene positions in Q2 2021 and 12 closed out, a net change of -11 holders.
  • The largest Adagene buyer in Q2 2021 was Morgan Stanley, an estimated $13.4M added.
  • The largest Adagene seller in Q2 2021 was Credit Suisse, an estimated $10.9M sold.

Based on aggregated 13F filings for Q2 2021.